Related Experiment Videos
[Treatment of acute myocardial infarction--an elucidative report]
Insights
Optimal acute myocardial infarction (AMI) treatment emphasizes rapid prehospital and hospital care, including thrombolysis and Aspirin. Early mobilization and risk-factor management are key for patient recovery and secondary prevention.
Area of Science:
- Cardiology
- Emergency Medicine
- Internal Medicine
Context:
- Acute myocardial infarction (AMI) management requires timely and evidence-based interventions.
- Current guidelines advocate for prompt prehospital and in-hospital care to improve patient outcomes.
Purpose:
- To review and outline the optimal, present-day treatment strategies for patients diagnosed with acute myocardial infarction (AMI).
- To provide a comprehensive overview of recommended interventions from prehospital care through discharge and secondary prevention.
Summary:
- Emphasizes minimizing prehospital delays and initiating prompt hospital treatment for AMI.
- Recommends thrombolysis for symptom onset within 6-12 hours and Aspirin, with beta-blockers for high-risk patients post-discharge.
- Details management of arrhythmias, cardiac failure, and advocates for early mobilization, patient education, and risk factor control (smoking cessation, lipid and blood pressure management).
Impact:
- Facilitates standardized, optimal care pathways for acute myocardial infarction patients.
- Highlights the importance of secondary prevention strategies to reduce recurrent events and mortality.
- Guides clinical decision-making for patient monitoring, discharge criteria, and referral for advanced procedures like coronary arteriography.
Abstract:
The present-day optimal treatment of patients with acute myocardial infarction (AMI) is reviewed. The prehospital phase should be as brief as possible. Emergency observation and treatment in hospital should be initiated without delay. Schematic stages for mobilization have been discarded and free mobilization is recommended. Routine acute intervention with thrombolysis is recommended for patients in whom symptoms have been present for 6-12 hours and treatment with Aspirin is recommended. Beta-blocking agents are recommended for patients with increased risk after discharge. Treatment of ventricular and supraventricular arrhythmias, block and cardiac failure are reviewed in detail. Patients without complications should be monitored for three to five days and may be discharged after seven to ten days. Exercise ECG should be carried out at discharge to assess the working capacity, ischaemia and subjective reaction. The importance of good patient information is emphasized. Cessation of smoking, control of lipids and blood pressure are important as secondary interventions. As far as possible, outpatient control should be offered after discharge. The criteria for referral to specialized cardiological departments are established both for emergency and elective referral. Patients under the age of 70 years with high risk for repeated AMI or death after discharge (with residual ischaemia) should possibly be referred for coronary arteriography.